Sun Mountain Capital

Sun Mountain Capital is a private equity firm established in 2006 and based in Santa Fe, New Mexico. The firm is composed of senior private equity professionals with extensive experience dating back to 1981. Its team has a proven track record in creating value through both fund advisory services and direct investments in promising companies. Sun Mountain Capital specializes in developing customized private equity programs for pension plans and other program sponsors, analyzing key success factors across various private equity initiatives to create tailored investment solutions that align with specific goals. The firm also operates as a Registered Investment Adviser.

Kevin Barber

Managing Director at Sun Mountain Capital

Dan Brooks

Principal

Sally Corning

Partner

Hal Hayden

Partner, Private Credit and Investment Committee Member

Lee Rand

Partner

50 past transactions

Uvera

Seed Round in 2023
Uvera Inc. is a technology company based in San Mateo, California, established in 2019. It specializes in developing innovative ultraviolet (UV) light technology that effectively extends the shelf life of fresh food. Uvera's portable devices utilize this technology to disinfect food from viruses, bacteria, and foodborne pathogens without the use of chemicals. The technology can double the shelf life of fresh produce, meat, and baked goods, typically achieving an average extension of up to 60% within just 30 seconds of application. Uvera's products cater to both consumers and the food and beverage industry, addressing the critical need for enhanced food preservation solutions.

Vega Cloud

Venture Round in 2022
Vega Cloud is a software-as-a-service (SaaS) application focused on managing public cloud infrastructure. It offers an enterprise management platform that simplifies the complexities of cloud deployment, allowing businesses to efficiently scale their operations. The platform provides optimization recommendations, helping organizations streamline their cloud management processes. By utilizing Vega Cloud, companies can save both time and money in their cloud deployments, making it easier to oversee their infrastructure effectively.

3D Glass Solutions

Series B in 2022
3D Glass Solutions provides customers complete glass-enabled systems integration services using their patented APEX® Glass. Their mission is to provide our customers with an integrative solution in electronics and IC packaging that allows them to integrate more components onto a single platform while decreasing overall manufacturing costs.

Armonica

Series B in 2021
Armonica Technologies derives its name from prolific innovator Benjamin Franklin’s favorite invention, The Glass Armonica. Armonica Technologies is an early stage medtech company focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications. The Company’s technology is based upon a portfolio of patented and patent pending technologies licensed from STC.UNM.

BayoTech

Series C in 2021
BayoTech, Inc. is a company based in Albuquerque, New Mexico, focused on developing innovative hydrogen generation systems. Established in 2015, BayoTech manufactures steam methane reformers and hydrogen transport solutions, including high-capacity, high-pressure transport trailers. The company aims to advance sustainability in the hydrogen sector by providing low-carbon hydrogen solutions that reduce transportation emissions and optimize supply chains through local production. BayoTech operates a growing network of hydrogen hubs, such as the operational site in Wentzville, Missouri, and an upcoming hub in Stockton, California. By centralizing the hydrogen supply chain, BayoTech offers a complete portfolio of hydrogen production, transport, storage, and fueling solutions, making reliable and cost-effective low-carbon hydrogen accessible to various sectors, including agriculture, fuel cells, and energy.

First Crop

Series A in 2021
First Crop is engaged in the development of farming technology that promotes environmentally sustainable practices for farmers. The company focuses on regenerative principles, including financial inclusion, empowered participation, and resource sharing. By providing USDA certified-organic hemp, First Crop enables the production of high-quality hemp-derived health and wellness products. This approach not only supports farmers in adopting sustainable methods but also facilitates easier access to CBD products for users.

UbiQD

Series A in 2020
UbiQD, LLC is a manufacturer of low-hazard semiconductor nanocrystals based in Los Alamos, New Mexico. Founded in 2014, the company specializes in producing low-toxicity quantum dots and polymer composites that are designed for a variety of applications, including agriculture, solar energy, and lighting. One of its key products, UbiGro, is a retrofit luminescent film that can be easily installed in greenhouses to enhance crop growth by optimizing sunlight. UbiQD's focus on creating inexpensive, cadmium-free quantum dots positions it to become a significant player in cleantech materials, facilitating collaborations with leading scientists in the region, particularly from Los Alamos and Sandia National Laboratories.

BennuBio

Series B in 2020
BennuBio, Inc. is a technology company specializing in the development of flow cytometry equipment designed for the sorting and analysis of cells and particles in various applications, particularly those requiring the recovery of rare cells. The company offers The Velocyt system, which enables the detection of rare events such as activated T cells, circulating tumor cells, and fetal cells in maternal blood, supporting advancements in personalized medicine and drug discovery. Additionally, BennuBio provides spheroid generation systems and high-volume sorting systems, along with technical and application support services. Founded in 2018 and based in Albuquerque, New Mexico, BennuBio focuses on delivering innovative cell analysis solutions that accommodate a wide range of sample sizes and particle dimensions.

mPower Technology

Series A in 2019
mPower Technology is an innovative solar cell technology startup.They are an experienced team of technology innovators and industry veterans out to shape the future of solar power around the globe.

Exagen

Venture Round in 2019
Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

3D Glass Solutions

Series B in 2019
3D Glass Solutions provides customers complete glass-enabled systems integration services using their patented APEX® Glass. Their mission is to provide our customers with an integrative solution in electronics and IC packaging that allows them to integrate more components onto a single platform while decreasing overall manufacturing costs.

Robotic Skies

Series A in 2019
Robotic Skies, Inc. is a provider of maintenance and repair services for commercial unmanned aircraft systems (UAS) and advanced air mobility aircraft (AAM). Founded in 2013 and based in Albuquerque, New Mexico, the company operates a global network of over 150 independently-owned repair stations. These stations are staffed by aviation professionals with expertise in maintaining both manned and unmanned aircraft, ensuring high standards of safety and efficiency. Robotic Skies offers a comprehensive field service program designed to keep UAS fleets operational and compliant with aviation regulations. This approach enables it to deliver specialized certification, maintenance, and repair services to emerging commercial drone operators worldwide.

BennuBio

Series A in 2018
BennuBio, Inc. is a technology company specializing in the development of flow cytometry equipment designed for the sorting and analysis of cells and particles in various applications, particularly those requiring the recovery of rare cells. The company offers The Velocyt system, which enables the detection of rare events such as activated T cells, circulating tumor cells, and fetal cells in maternal blood, supporting advancements in personalized medicine and drug discovery. Additionally, BennuBio provides spheroid generation systems and high-volume sorting systems, along with technical and application support services. Founded in 2018 and based in Albuquerque, New Mexico, BennuBio focuses on delivering innovative cell analysis solutions that accommodate a wide range of sample sizes and particle dimensions.

RiskSense

Series B in 2018
RiskSense, Inc. specializes in cyber risk management solutions, offering a cloud-based platform that enables organizations to assess and manage their cybersecurity risks effectively. The RiskSense Platform allows users to evaluate their cyber risk exposure across a broad attack surface, orchestrate remediation efforts, and monitor outcomes. Key services include RiskSense Vulnerability Discovery, which provides regular vulnerability assessments to identify security weaknesses, and RiskSense Attack Surface Validation, which assesses vulnerabilities that could be exploited by cyber adversaries. The platform employs risk-based scoring and analytics to present a comprehensive view of cybersecurity risks, allowing organizations to prioritize remediation activities based on critical security weaknesses. Founded in 2006 and headquartered in Sunnyvale, California, RiskSense also has offices in Albuquerque, New Mexico, and India.

Agilvax

Series A in 2018
Agilvax is a private company that discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases. The company identifies and selects lead vaccine candidates through its proprietary affinity optimizes those by in vitro and in vivo testing and develops them through pre-clinical and/or clinical testing until proof of concept is achieved establishing attractive out-licensing opportunities to Pharma or Biotech partners. Collaborations and partnerships are actively pursued within the industry, academia, and the government sector through NIAID.

BayoTech

Series B in 2018
BayoTech, Inc. is a company based in Albuquerque, New Mexico, focused on developing innovative hydrogen generation systems. Established in 2015, BayoTech manufactures steam methane reformers and hydrogen transport solutions, including high-capacity, high-pressure transport trailers. The company aims to advance sustainability in the hydrogen sector by providing low-carbon hydrogen solutions that reduce transportation emissions and optimize supply chains through local production. BayoTech operates a growing network of hydrogen hubs, such as the operational site in Wentzville, Missouri, and an upcoming hub in Stockton, California. By centralizing the hydrogen supply chain, BayoTech offers a complete portfolio of hydrogen production, transport, storage, and fueling solutions, making reliable and cost-effective low-carbon hydrogen accessible to various sectors, including agriculture, fuel cells, and energy.

Robotic Skies

Seed Round in 2017
Robotic Skies, Inc. is a provider of maintenance and repair services for commercial unmanned aircraft systems (UAS) and advanced air mobility aircraft (AAM). Founded in 2013 and based in Albuquerque, New Mexico, the company operates a global network of over 150 independently-owned repair stations. These stations are staffed by aviation professionals with expertise in maintaining both manned and unmanned aircraft, ensuring high standards of safety and efficiency. Robotic Skies offers a comprehensive field service program designed to keep UAS fleets operational and compliant with aviation regulations. This approach enables it to deliver specialized certification, maintenance, and repair services to emerging commercial drone operators worldwide.

TriLumina Corp.

Venture Round in 2017
TriLumina delivers industry-leading VCSEL illumination solutions for 3D sensing and LiDAR in automotive, industrial and mobile markets. These patented innovations in VCSEL technology for 3D-sensing and LiDAR enable fast development of tomorrow’s technologies. As the preferred industry platform, TriLumina illumination solutions democratize and advance a range of applications—from AR/VR, 3D-cameras to self-driving cars and beyond.

RiskSense

Series A in 2017
RiskSense, Inc. specializes in cyber risk management solutions, offering a cloud-based platform that enables organizations to assess and manage their cybersecurity risks effectively. The RiskSense Platform allows users to evaluate their cyber risk exposure across a broad attack surface, orchestrate remediation efforts, and monitor outcomes. Key services include RiskSense Vulnerability Discovery, which provides regular vulnerability assessments to identify security weaknesses, and RiskSense Attack Surface Validation, which assesses vulnerabilities that could be exploited by cyber adversaries. The platform employs risk-based scoring and analytics to present a comprehensive view of cybersecurity risks, allowing organizations to prioritize remediation activities based on critical security weaknesses. Founded in 2006 and headquartered in Sunnyvale, California, RiskSense also has offices in Albuquerque, New Mexico, and India.

SBA Materials

Series D in 2015
SBA Materials, Inc. specializes in the development and commercialization of advanced electronic materials tailored for the semiconductor manufacturing industry, particularly in back-end of line and packaging applications. Founded in 2001 and based in Albuquerque, New Mexico, the company focuses on low-k dielectric materials for interlayer dielectric applications, addressing significant needs in the sector. Its product offerings include uLK22, uLK1X, and various optical films, along with nano-porous and meso-porous materials. These materials can be utilized in diverse forms such as thin films, powders, and fibers, and can be chemically functionalized for applications in electronics, optics, sensors, and catalysts. The company operates from a facility at the Science and Technology Park, which features R&D laboratories and is strategically located near the University of New Mexico and the Sandia National Laboratories Materials Research Center. SBA Materials aims to enhance the performance of electronic devices while reducing power consumption, thereby supporting manufacturers in producing more efficient logic chips.

Seamless Medical Systems

Venture Round in 2015
Seamless Medical Systems, LLC specializes in developing cloud-based software and services aimed at enhancing the operational efficiency of physician practices while improving patient communication. Its flagship product, SNAP Practice, serves as a comprehensive patient engagement platform that facilitates data capture, registration, and health education. The company also offers SNAP EXPRESS, a patient engagement tool that includes features such as digital registration and personalized health education, as well as SNAP ENTERPRISE, which integrates with electronic medical records and practice management systems. Additional offerings include SNAPedu, an educational platform delivering health information at the point of care, and SNAPdash, a dashboard providing insights into patient registration workflows. Seamless Medical Systems caters to a diverse range of healthcare practitioners across the United States, and is based in Santa Fe, New Mexico. The company was incorporated in 2010 and operates as a subsidiary of GetWellNetwork, Inc.

TriLumina Corp.

Series B in 2015
TriLumina delivers industry-leading VCSEL illumination solutions for 3D sensing and LiDAR in automotive, industrial and mobile markets. These patented innovations in VCSEL technology for 3D-sensing and LiDAR enable fast development of tomorrow’s technologies. As the preferred industry platform, TriLumina illumination solutions democratize and advance a range of applications—from AR/VR, 3D-cameras to self-driving cars and beyond.

Respira Therapeutics

Convertible Note in 2015
Respira is a product development-stage company focused on pulmonary delivery of therapeutics for respiratory diseases with unmet medical needs. The company realized seed capitalization from the Cottonwood Technology Fund on October 2010 for scientific development and commercialization of its patent pending technology for passive dry powder inhalers (DPI), consisting of a unique drug delivery engine with a novel, patent pending mechanism of action for lung delivery and therapy. Clinical proof-of-principle has been achieved. Respira Therapeutics DPIs have demonstrated "best-in-class" drug dispersion performance, and are uniquely positioned to replace currently marketed devices and to broaden inhaled therapies to drug classes/disease indications in high value therapeutic areas by virtue of superior performance and payload outcomes.

Aspen Avionics

Venture Round in 2014
Aspen Avionics, based in Albuquerque, New Mexico, was founded by aviation enthusiasts in 2004. The company specializes in bringing the most advanced technology and capability into general aviation cockpits. Its products increase situational awareness and reduce pilot workload, making it even easier and safer to fly in both VFR and IFR conditions. The company’s philosophy is that getting the latest avionics technology shouldn’t always mean spending a lot of money—on equipment or on installation.

Respira Therapeutics

Convertible Note in 2014
Respira is a product development-stage company focused on pulmonary delivery of therapeutics for respiratory diseases with unmet medical needs. The company realized seed capitalization from the Cottonwood Technology Fund on October 2010 for scientific development and commercialization of its patent pending technology for passive dry powder inhalers (DPI), consisting of a unique drug delivery engine with a novel, patent pending mechanism of action for lung delivery and therapy. Clinical proof-of-principle has been achieved. Respira Therapeutics DPIs have demonstrated "best-in-class" drug dispersion performance, and are uniquely positioned to replace currently marketed devices and to broaden inhaled therapies to drug classes/disease indications in high value therapeutic areas by virtue of superior performance and payload outcomes.

SBA Materials

Series C in 2014
SBA Materials, Inc. specializes in the development and commercialization of advanced electronic materials tailored for the semiconductor manufacturing industry, particularly in back-end of line and packaging applications. Founded in 2001 and based in Albuquerque, New Mexico, the company focuses on low-k dielectric materials for interlayer dielectric applications, addressing significant needs in the sector. Its product offerings include uLK22, uLK1X, and various optical films, along with nano-porous and meso-porous materials. These materials can be utilized in diverse forms such as thin films, powders, and fibers, and can be chemically functionalized for applications in electronics, optics, sensors, and catalysts. The company operates from a facility at the Science and Technology Park, which features R&D laboratories and is strategically located near the University of New Mexico and the Sandia National Laboratories Materials Research Center. SBA Materials aims to enhance the performance of electronic devices while reducing power consumption, thereby supporting manufacturers in producing more efficient logic chips.

xF Technologies

Debt Financing in 2014
xF Technologies Inc. specializes in the production of specialty chemicals by converting renewable biomass materials, such as cornstarch and sugarcane, into nontoxic and sustainable chemical products. The company offers a range of products, including methyl, ethyl, and isopropyl compounds, as well as plasticizers for the PVC market and various solvents for cleaning and processing applications. Additionally, xF Technologies develops innovative biofuels and petrochemical replacements through its patented molecular platform, which enhances environmental performance while providing cost savings. Founded in 2007 and headquartered in Albuquerque, New Mexico, the company aims to deliver solutions that improve environmental health and safety ratings across various industries, including agriculture, personal care, and paints and coatings.

TriLumina Corp.

Series A in 2014
TriLumina delivers industry-leading VCSEL illumination solutions for 3D sensing and LiDAR in automotive, industrial and mobile markets. These patented innovations in VCSEL technology for 3D-sensing and LiDAR enable fast development of tomorrow’s technologies. As the preferred industry platform, TriLumina illumination solutions democratize and advance a range of applications—from AR/VR, 3D-cameras to self-driving cars and beyond.

xF Technologies

Series A in 2014
xF Technologies Inc. specializes in the production of specialty chemicals by converting renewable biomass materials, such as cornstarch and sugarcane, into nontoxic and sustainable chemical products. The company offers a range of products, including methyl, ethyl, and isopropyl compounds, as well as plasticizers for the PVC market and various solvents for cleaning and processing applications. Additionally, xF Technologies develops innovative biofuels and petrochemical replacements through its patented molecular platform, which enhances environmental performance while providing cost savings. Founded in 2007 and headquartered in Albuquerque, New Mexico, the company aims to deliver solutions that improve environmental health and safety ratings across various industries, including agriculture, personal care, and paints and coatings.

Exagen

Debt Financing in 2013
Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

Respira Therapeutics

Series A in 2013
Respira is a product development-stage company focused on pulmonary delivery of therapeutics for respiratory diseases with unmet medical needs. The company realized seed capitalization from the Cottonwood Technology Fund on October 2010 for scientific development and commercialization of its patent pending technology for passive dry powder inhalers (DPI), consisting of a unique drug delivery engine with a novel, patent pending mechanism of action for lung delivery and therapy. Clinical proof-of-principle has been achieved. Respira Therapeutics DPIs have demonstrated "best-in-class" drug dispersion performance, and are uniquely positioned to replace currently marketed devices and to broaden inhaled therapies to drug classes/disease indications in high value therapeutic areas by virtue of superior performance and payload outcomes.

xF Technologies

Series A in 2013
xF Technologies Inc. specializes in the production of specialty chemicals by converting renewable biomass materials, such as cornstarch and sugarcane, into nontoxic and sustainable chemical products. The company offers a range of products, including methyl, ethyl, and isopropyl compounds, as well as plasticizers for the PVC market and various solvents for cleaning and processing applications. Additionally, xF Technologies develops innovative biofuels and petrochemical replacements through its patented molecular platform, which enhances environmental performance while providing cost savings. Founded in 2007 and headquartered in Albuquerque, New Mexico, the company aims to deliver solutions that improve environmental health and safety ratings across various industries, including agriculture, personal care, and paints and coatings.

TriLumina Corp.

Series A in 2013
TriLumina delivers industry-leading VCSEL illumination solutions for 3D sensing and LiDAR in automotive, industrial and mobile markets. These patented innovations in VCSEL technology for 3D-sensing and LiDAR enable fast development of tomorrow’s technologies. As the preferred industry platform, TriLumina illumination solutions democratize and advance a range of applications—from AR/VR, 3D-cameras to self-driving cars and beyond.

Aspen Avionics

Series C in 2012
Aspen Avionics, based in Albuquerque, New Mexico, was founded by aviation enthusiasts in 2004. The company specializes in bringing the most advanced technology and capability into general aviation cockpits. Its products increase situational awareness and reduce pilot workload, making it even easier and safer to fly in both VFR and IFR conditions. The company’s philosophy is that getting the latest avionics technology shouldn’t always mean spending a lot of money—on equipment or on installation.

Exagen

Series C in 2012
Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

Exagen

Venture Round in 2012
Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

Exagen

Venture Round in 2011
Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

Skorpios Technologies

Series B in 2011
Skorpios Technologies, Inc. is a fabless semiconductor company based in Albuquerque, New Mexico, specializing in silicon photonic integrated circuit products. Founded in 2009, the company develops and markets a range of opto-electronic integrated circuits, including 100G-CWDM system-on-chip receivers and transmitters. Skorpios Technologies also offers innovative solutions such as Template Assisted Bonding, which supports high-speed video, data, and voice communications across networking, cloud computing, storage, and cable TV applications. Additionally, the company provides gain materials, wafer-scale processes, uncooled tunable laser technology, and coherent transceiver devices. By designing and manufacturing integrated optical modules and subsystems, Skorpios enables high-bandwidth interconnectivity at competitive manufacturing costs, serving various sectors including aerospace and defense, bioelectronics, and communications.

NanoMR

Series B in 2011
nanoMR has developed the first system for rapid isolation of rare cells from complex matrices at levels of 1 cell/mL or lower. The immunomagnetic capture system can target multiple cell types simultaneously, for example capturing bacteria and fungi from bloodstream infections, or specific cell types, such as circulating tumor, or fetal, cells, in less than 30 minutes.

Exagen

Venture Round in 2011
Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

Exagen

Venture Round in 2011
Exagen Inc. is a diagnostics company focused on improving the care of patients with autoimmune diseases through the development and commercialization of innovative testing products under its AVISE brand. Utilizing its proprietary Cell-Bound Complement Activation Products technology, Exagen offers a range of tests aimed at the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune-related disorders, such as systemic lupus erythematosus and rheumatoid arthritis. Among its key products are AVISE CTD, which supports differential diagnosis for connective tissue diseases, and AVISE Lupus, which assesses complement system activation. The company's portfolio also includes AVISE APS for antiphospholipid syndrome, AVISE SLE Prognostic for risk assessment of complications, and tests for monitoring treatment efficacy in rheumatoid arthritis. Established in 2002 and headquartered in Vista, California, Exagen is dedicated to providing rheumatologists with timely and accurate diagnostic tools to enhance patient care.

JackRabbit Systems

Venture Round in 2010
JackRabbit Systems is a technology company focused on serving the global travel industry. It develops a comprehensive platform that includes a booking referral engine, event management software, and marketing performance insights data. Additionally, the company provides event marketing tools and channel distribution solutions, all designed to equip travel companies with software that generates actionable insights. By offering these innovative solutions, JackRabbit Systems aims to enhance efficiency and effectiveness in travel marketing and event management.

Lumidigm

Series C in 2008
Lumidigm Inc. is a biometric technology company focused on delivering secure and reliable identification and verification solutions. The company specializes in developing identification technology that utilizes optical skin tissue measurements to produce high-quality images consistently, regardless of environmental conditions. Lumidigm's biometric identity management services are applicable across various sectors, including civil identification, point-of-sale systems, time and attendance tracking, and both physical and logical access control. Additionally, their technology extends to portable electronic device applications, ensuring that everyone is identifiable in a convenient manner.

Aspen Avionics

Series B in 2007
Aspen Avionics, based in Albuquerque, New Mexico, was founded by aviation enthusiasts in 2004. The company specializes in bringing the most advanced technology and capability into general aviation cockpits. Its products increase situational awareness and reduce pilot workload, making it even easier and safer to fly in both VFR and IFR conditions. The company’s philosophy is that getting the latest avionics technology shouldn’t always mean spending a lot of money—on equipment or on installation.

Advent Solar

Series D in 2007
Advent Solar produces silicon photovoltaic cell-to-module technology. Based in Albuquerque, New Mexico, U.S.A., the company focuses on delivering intellectual property (IP) for intelligent, high-energy silicon photovoltaic (PV) solutions. With patented, advanced technologies, Advent Solar enables higher value products that are Beautiful by Design™, changing the rules for smart grid economics. Advent Solar provides its industry-leading Ventura™ Technology through a licensing model. Ventura Solar Technology is a comprehensive cell-to-module architecture for high-performance solar modules that deliver the industry’s best value for silicon PV modules.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.